Multiple Environmental Exposures Jointly Contribute to Asthma Risk
By Elana Gotkine HealthDay Reporter
WEDNESDAY, May 28, 2025 -- Air pollution, built environment, and ambient temperature jointly contribute to incident asthma risk, according to a study published online May 15 in The Lancet Regional Health: Europe.
Zhebin Yu, Ph.D., from the Karolinska Institutet in Stockholm, and colleagues analyzed data from 14 European cohorts to examine the impact of the urban exposome on asthma incidence. Three external exposome domains (air pollution, built environment, and ambient temperature) were linked to participants' home addresses at baseline.
The researchers identified 7,428 incident asthma cases among 349,037 participants from birth to age 70 years or older. The risks for asthma were higher for clusters characterized by high particulate matter and nitrogen dioxide exposure in adults (odds ratio, 1.13) and for clusters characterized by high built-up area and low levels of greenness in children and adults (odds ratios, 1.36 and 1.15 for birth cohorts and adult cohorts, respectively). Higher risks for incident asthma were consistently associated with the joint exposure using the environment risk score combining the three domains (odds ratio, 1.13 for birth cohorts; odds ratio, 1.15 for adult cohorts per 20 percent increase). Of the incident asthma cases, 11.6 percent could be attributed to an environmental risk score above cohort-specific median levels.
"We found that the joint exposure to multiple hazardous urban environmental factors, including air pollution, lack of greenness, and higher built-up areas, was consistently associated with a higher risk of incident asthma across the cohorts," the authors write.
One author disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted May 2025
Read this next
Molgramostim Beneficial in Autoimmune Pulmonary Alveolar Proteinosis
THURSDAY, Aug. 21, 2025 -- In adults with autoimmune pulmonary alveolar proteinosis (aPAP), once-daily inhaled molgramostim, a recombinant human granulocyte-macrophage...
GERD Linked to Increased Incidence of Pulmonary Disease
TUESDAY, Aug. 19, 2025 -- The presence of gastroesophageal reflux disease (GERD) is associated with an increased incidence of pulmonary diseases, but this effect may be attenuated...
Six in 10 Children With Asthma Meet Guideline Diagnostic Criteria
THURSDAY, Aug. 14, 2025 -- Roughly two-thirds of children with pediatrician-diagnosed asthma have a confirmed diagnosis in accordance with international guideline criteria...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.